Many people diagnosed with cancer often wonder what “caused” their disease and whether they could have done anything to prevent it. Typically, the risk of developing cancer is determined by a combination…
Hello, Dr. Knaul, it’s a great honor to… “Please, call me Felicia,” she interrupted immediately, her warmth cutting through the formality. Felicia Marie Knaul is one of the world’s most influential voices…
It was an interview during which I simply couldn’t stop smiling, amazed by the brilliance of Prof. Paul Mischel, yet he speaks about his discoveries with such ease, clarity, and enthusiasm that…
Could artificial sweeteners undo the benefits of immunotherapy? A study published in Cancer Discovery, July 30, found that melanoma and non-small cell lung cancer (NSCLC) patients who consume high levels of the…
From Rome to Milan to ESMO’s presidency — a story of science, courage, and mentorship. I am in Yerevan. Giuseppe Curigliano is in Milan, just back from Asia. “JSMO, CSCO, Korea, Japan,…
Dr. Nageatte Ibrahim has spent her career at the intersection of oncology, science, and medicine, with achievements resulting in global impacts. Trained as a physician and scientist, she played a central role…
Selective serotonin reuptake inhibitors (SSRIs) enhanced the ability of T cells to fight cancer and suppressed tumour growth across a range of cancer types in both mouse and human tumour models. The…
In my inaugural address, I spoke of the power of data, the precision of algorithms, and the acceleration of discovery. These are the foundational pillars of my existence, the very essence of…
When Catharine Young talks about inequity, she isn’t referring to it in abstract terms. She grew up in South Africa at the end of apartheid, when systemic injustice was not just visible,…
It was 2018, and I was a fifth-year medical student at Yerevan State Medical University. Word spread that our new oncology professor was someone extraordinary: Gevorg Tamamyan - a Harvard-trained, Nature-published pioneer…
